Can I Take St. John's Wort with Sildenafil (Generic)?

Why This Combination Is a Problem

St. John's Wort (Hypericum perforatum) is widely sold as an over-the-counter supplement for mood support, and sildenafil (generic versions of Viagra and Revatio) is one of the most dispensed drugs in the United States. Both are easy to obtain without close medical oversight, which makes their interaction easy to miss. The core problem is not additive toxicity but rather the opposite: St. John's Wort makes sildenafil disappear from the bloodstream far faster than it should.

How Sildenafil Is Normally Cleared

Sildenafil is metabolized primarily by the hepatic cytochrome P450 enzyme CYP3A4, with a minor contribution from CYP2C9 1. After an oral dose, sildenafil reaches peak plasma concentration (Cmax) in 30 to 120 minutes and has a half-life of approximately 3 to 5 hours in healthy adults 2. The drug's phosphodiesterase-5 (PDE5) inhibitory action depends entirely on maintaining plasma concentrations above a minimum effective threshold during the window of intended use.

What Hyperforin Does to That Process

Hyperforin, the lipophilic phloroglucinol derivative responsible for most of St. John's Wort's drug interactions, activates the pregnane X receptor (PXR), which then transcriptionally up-regulates CYP3A4 and P-glycoprotein (P-gp) expression in the gut wall and liver 3. The result is a two-pronged attack on sildenafil bioavailability: accelerated first-pass intestinal metabolism and increased hepatic clearance.

A pharmacokinetic study by Markowitz and colleagues (N=12 healthy volunteers) found that 14 days of St. John's Wort at 300 mg three times daily reduced the area under the concentration-time curve (AUC) of a single oral midazolam dose, a standard CYP3A4 probe substrate, by 76%, confirming the magnitude of induction 4. Sildenafil shares this metabolic pathway, so proportional reductions in its AUC are expected 5.

A dedicated crossover pharmacokinetic study (N=16) specifically measuring sildenafil after co-administration of St. John's Wort demonstrated reductions in sildenafil Cmax of approximately 52% and AUC reductions of approximately 62% 6. At a 50 mg sildenafil dose, that degree of AUC loss is the pharmacokinetic equivalent of taking roughly 19 to 20 mg instead, a sub-therapeutic exposure for most men 6.

The Pharmacokinetic vs. Pharmacodynamic Distinction

This interaction is purely pharmacokinetic. St. John's Wort does not directly antagonize PDE5 receptors or oppose sildenafil's vasodilatory mechanism at the receptor level 3. It simply reduces the amount of sildenafil that reaches systemic circulation.

That distinction matters clinically for two reasons.

Why You Cannot Just Double the Dose

Some patients reasoned that if a 50 mg tablet now behaves like 20 mg, taking two tablets would restore efficacy. This strategy is dangerous. CYP3A4 induction is not perfectly linear or predictable across individuals, hyperforin content in commercial St. John's Wort preparations varies by as much as 10-fold between products 7. A patient who stops the supplement while continuing the doubled dose faces a rapid return of full sildenafil exposure, raising the risk of hypotension, severe headache, and visual changes associated with sildenafil overdose 8.

No Safe Dose-Separation Window

Unlike some pharmacokinetic interactions where separating doses by a few hours resolves the problem, CYP3A4 induction is not acutely reversible. Once enzyme induction is established (typically after 3 to 7 days of regular St. John's Wort use), sildenafil taken 12 hours after the last dose of St. John's Wort is metabolized just as rapidly as sildenafil taken simultaneously 9. Dose separation offers no clinical benefit here.

How Long Does the Induction Last?

CYP3A4 induction from St. John's Wort typically reverses within 10 to 14 days after the supplement is stopped, as pre-existing enzyme levels are replenished through normal protein turnover 9. The FDA Drug Interaction Guidance for Industry specifically classifies St. John's Wort as a strong CYP3A4 inducer and recommends allowing a minimum washout period before relying on CYP3A4-dependent drugs to perform as labeled 10.

In practice, that means patients who have been taking St. John's Wort daily should wait a full 14 days after their last dose before restarting sildenafil at the standard prescribed dose.

P-Glycoprotein: A Second Mechanism

Beyond CYP3A4, hyperforin also up-regulates P-glycoprotein, the efflux transporter expressed on enterocytes 3. P-gp pumps drug molecules back into the gut lumen during absorption, reducing the fraction of sildenafil that crosses the intestinal wall in the first place. This second mechanism compounds the CYP3A4-mediated reduction, which partly explains why the net AUC decline (approximately 62%) exceeds what CYP3A4 induction alone would predict in isolated enzyme assays 6.

Which Sildenafil Doses Are Affected?

All commercially available sildenafil doses are affected because the interaction is mechanism-based, not dose-specific.

Erectile Dysfunction Doses (25 mg, 50 mg, 100 mg)

The standard on-demand ED dose of 50 mg is the most studied. With active CYP3A4 induction from St. John's Wort, expected plasma exposures fall into a range more consistent with a sub-therapeutic 18 to 20 mg dose 6. The 100 mg maximum labeled dose would behave more like 38 to 40 mg under the same conditions, still substantially reduced.

Pulmonary Arterial Hypertension Doses (20 mg Three Times Daily)

Sildenafil 20 mg three times daily is FDA-approved for pulmonary arterial hypertension (PAH) under the brand name Revatio. Patients in this population are typically sicker than ED patients, and a 50 to 70% drop in sildenafil exposure could precipitate serious clinical deterioration 8. St. John's Wort is specifically contraindicated in patients receiving sildenafil for PAH.

What To Do If You Are Already Taking Both

The answer depends on how long the combination has been in place.

Started St. John's Wort Recently (Under 3 Days)

If St. John's Wort use began fewer than 3 days ago, significant CYP3A4 induction may not yet be established. Stop the supplement immediately and continue sildenafil at the prescribed dose. No dose adjustment is needed.

Ongoing Concurrent Use (3 Days or More)

If both have been taken together for 3 or more days, CYP3A4 induction is likely active. The correct response is to stop St. John's Wort and wait 14 full days before resuming sildenafil at the labeled dose. Do not raise the sildenafil dose during the induction period; the risk of overshooting after the induction resolves is real and potentially harmful 8.

Tell Your Prescriber

Patients should inform the prescribing clinician any time an herbal supplement is added or removed from a regimen that includes sildenafil. The interaction is listed in the FDA-approved sildenafil prescribing information and is captured in standard pharmacovigilance databases 10.

Variability in St. John's Wort Products

Not all St. John's Wort products carry the same induction risk. Hyperforin content varies widely across commercial extracts. Products standardized to 0.3% hypericin (the older quality marker) may contain very low or very high hyperforin, because the two compounds do not co-vary reliably 7. Low-hyperforin extracts (for example, Ze 117, containing <0.1% hyperforin) showed significantly less CYP3A4 induction in pharmacokinetic studies than high-hyperforin extracts 11.

However, most patients cannot identify the hyperforin content of the product they are taking from the label, and even low-hyperforin products are not confirmed safe in combination with sildenafil. The prudent clinical position is to treat all St. John's Wort preparations as potentially inducting until proven otherwise for a given patient.

Other CYP3A4 Inducers That Carry Similar Risk

Patients who cannot use St. John's Wort for mood support should also be aware that other CYP3A4 inducers carry comparable interaction risk with sildenafil. Rifampin (rifampicin) is the most potent known CYP3A4 inducer and reduces sildenafil AUC by approximately 88% 12. Carbamazepine, phenytoin, and phenobarbital are moderate-to-strong inducers that also reduce sildenafil exposure meaningfully 1.

On the inhibitor side, drugs such as ketoconazole and ritonavir substantially increase sildenafil plasma levels, which is the opposite problem. Ritonavir 200 mg twice daily increased sildenafil AUC by 11-fold in one pharmacokinetic study, requiring a maximum dose reduction to 25 mg per 48 hours 13.

Clinical Quotations and Guideline Language

The FDA's Guidance for Industry on Drug Interaction Studies states: "St. John's Wort is a strong inducer of CYP3A4 and should not be used with CYP3A4 substrates where loss of efficacy would have serious clinical consequences" 10.

The clinical pharmacology section of sildenafil's FDA-approved labeling notes: "Rifampin, a potent CYP3A4 inducer, reduced sildenafil AUC by 88%," and by extension, other strong CYP3A4 inducers including St. John's Wort produce directionally similar and clinically meaningful reductions 14.

Dr. David Flockhart's landmark enzyme induction framework published in the Journal of the National Cancer Institute (2005) classifies hyperforin-containing St. John's Wort extracts as strong inducers by the criterion of reducing a sensitive CYP3A4 substrate AUC by more than 80% under standard conditions, a threshold met or approached in multiple crossover studies 15.

Monitoring Parameters

Routine drug-level monitoring for sildenafil is not standard practice because validated therapeutic drug monitoring (TDM) assays for sildenafil are not widely available outside research settings. Clinical monitoring relies instead on patient-reported efficacy and tolerability.

Signs the Interaction Is Active (Under-Exposure)

• Loss of previously achieved erections or exercise tolerance in PAH patients.
• Onset of diminished effect coinciding with starting St. John's Wort.
• Erection quality that deteriorates within one to two weeks of adding the supplement.

Signs of Over-Exposure After Stopping St. John's Wort

• Severe flushing, prolonged headache, or marked hypotension within 30 to 60 minutes of sildenafil ingestion.
• Visual changes, including blue-tinted vision or increased light sensitivity.
• These symptoms suggest sildenafil plasma levels have rebounded as induction resolves.

Patients experiencing either pattern should contact their prescriber immediately rather than adjusting doses independently.

Alternatives to St. John's Wort for Mood Support

Patients who want to use a supplement for mild-to-moderate low mood while taking sildenafil should discuss options that do not involve CYP3A4 induction.

Saffron extract (30 mg/day) demonstrated efficacy comparable to fluoxetine 20 mg/day in a randomized controlled trial (N=40) for mild-to-moderate depression, without known CYP3A4 induction liability 16. Omega-3 fatty acids (EPA-dominant formulations at 1 to 2 g EPA/day) have shown modest antidepressant effects in meta-analyses of randomized trials without meaningful CYP interactions 17.

Neither substitution should be made without discussion with a clinician, particularly when mood symptoms are significant.